Rare Disease Genetic Testing Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Rare Disease Genetic Testing Market Size By 2025?
The market size for genetic testing of rare diseases has seen a swift expansion in the recent past. Projections show the market will increase from $1.03 billion in 2024 to $1.17 billion in 2025, displaying a compound annual growth rate (CAGR) of 13.6%. The notable growth observed in the past is due to factors such as enhanced awareness of rare genetic disorders, a mounting demand for timely and precise diagnosis, an upsurge in government backing for research on rare diseases, the growing accessibility of genetic testing services, an escalation in investments in precision medicine, and a rise in the occurrence of rare genetic conditions.

How Big Is the Rare Disease Genetic Testing Market Size Expected to Grow by 2029?
The market size for rare disease genetic testing is anticipated to experience a swift expansion in the coming years. By 2029, the market is predicted to reach $1.93 billion with a Compound Annual Growth Rate (CAGR) of 13.3%. The growth expected in the forecast period is linked to various factors such as increased use of next-generation sequencing, higher emphasis on personalized medicine, heightened investment in genetics study, expanded medical facilities in developing markets, an increase in diagnostic testing, a surge in hereditary cancer testing, and increased demand for non-invasive diagnostic options. Key developments anticipated in the forecast period include progression in genome editing technologies, sophisticated tools for genetic data analysis, innovations in multi-gene panel testing, growth in portable genetic testing devices, and novelty in sample collection techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/rare-disease-genetic-testing-global-market-report

Which Key Market Drivers Powering Rare Disease Genetic Testing Market Expansion and Growth?
The rise in genetic disorders is projected to stimulate the expansion of the rare disease genetic testing market in the future. Genetical anomalies, which can result in medical conditions, are the result of anomalies in a person's deoxyribonucleic acid either passed down from one or both parents, or from new mutations. The rise in these disorders can be linked back to parents of an older age, who are more likely to pass on genetic mutations to offspring. Rare disease genetic testing facilitates the accurate and early identification of these disorders by pinpointing specific mutations. This enables tailored treatment plans to be developed, which can lead to improved patient care and healthier long-term outcomes. For instance, statistics from the National Health Service, a UK-based government agency, in May 2024 noted that there are 17,000 people in the UK living with sickle cell disease, a genetically inherited blood disorder. Approximately 250 new cases are diagnosed each year. Consequently, the rise in genetic disorders is fueling the growth of the rare disease genetic testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27404&type=smp

What Long-Term Trends Will Define the Future of the Rare Disease Genetic Testing Market?
In the market for rare disease genetic testing, main enterprises are prioritizing the creation of hi-tech solutions like digital genomics platforms. These platforms, designed to increase diagnosis speed, accuracy, and scale, are elaborate software systems that assist with the analysis, interpretation, and reporting of genomic data, thus enhancing the process of genetic testing and diagnosis. An example of this is when Strand Life Sciences Private Limited, a computer software company based in India, in March 2025, launched StrandOmics Portal. This digital platform is tailored to upgrade the efficiency and exactness in diagnosing rare diseases. It provides in-depth information on genetic variations to clinicians, allowing for quicker and more exact diagnoses. It also supports sophisticated interpretation of variants, including prenatal diagnostics, and encourages independent examination of genetic data. This launch demonstrates a substantial commitment to developing precision medicine and supplying medical practitioners with effective tools to improve patient outcomes.

What Are the Emerging Segments in the Rare Disease Genetic Testing Market?
The rare disease genetic testing market covered in this report is segmented

1) By Disease Type: Immunological Disorders, Cardiovascular Disorders, Neurological Disease, Endocrine And Metabolism Disorders Diseases, Hematological Diseases, Dermatological Disease, Other Disease Types
2) By Technology: Next-Generation Sequencing, Sanger Sequencing, Polymerase Chain Reaction Based Testing, Array Based Testing, Fluorescence In Situ Hybridization, Other Technologies
3) By Specialty: Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests
4) By End-User: Hospitals And Clinics, Research Laboratories And Contract Research Organizations, Diagnostic Laboratories, Other End Users

Subsegments:
1) By Immunological Disorders: Autoimmune Disorders, Allergic Conditions, Primary Immunodeficiency Disorders, Inflammatory Disorders
2) By Cardiovascular Disorders: Congenital Heart Defects, Cardiomyopathies, Aortic Aneurysms, Pulmonary Hypertension
3) By Neurological Disease: Neurodegenerative Disorders, Neuromuscular Disorders, Epileptic Syndromes, Movement Disorders
4) By Endocrine And Metabolism Disorders Diseases: Inherited Metabolic Disorders, Thyroid Disorders, Adrenal Disorders, Diabetes Related Genetic Conditions
5) By Hematological Diseases: Hemophilia, Thalassemia, Sickle Cell Disease, Clotting Disorders
6) By Dermatological Disease: Genetic Skin Disorders, Connective Tissue Disorders, Pigmentary Disorders, Keratinization Disorders
7) By Other Disease Types: Skeletal Dysplasia, Renal Genetic Disorders, Ophthalmic Genetic Conditions, Gastrointestinal Genetic Conditions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27404&type=smp

Who Are the Global Leaders in the Rare Disease Genetic Testing Market?
Major companies operating in the rare disease genetic testing market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Natera Inc., OPKO Health Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BioReference Laboratories Inc., Invitae Corporation, Ambry Genetics Corporation, Centogene N.V., Baylor Genetics Company, PreventionGenetics, Blueprint Genetics Oy, Realm IDX Inc., Artemis DNA Inc., BGI Genomics Co. Ltd.

Which are the Top Profitable Regional Markets for the Rare Disease Genetic Testing Industry?
North America was the largest region in the rare disease genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27404

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.